To study the prevalence, non-invasive diagnostics and evolution of non-alcoholic-fatty-liver-disease (NAFLD) in patients with polycystic ovary syndrome (PCOS)
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Prevalence of NAFLD
Timeframe: Baseline and at follow-up 1 year later.
Prevalence of NAFLD in PCOS
Timeframe: Baseline